About the Report
The increasing incidence of breast cancer and prostate cancer has necessitated innovation in single-dose radiotherapy. As per the Centers for Disease Control and Prevention (CDC), prostate cancer is the second most frequently occurring type of cancer in men above the age of 45 years and breast cancer is one of the leading types of cancer among women across the globe.
Single-dose radiotherapy offers advantages such as high precision, greater patient comfort, cost-effectiveness, and better cosmetic outcomes in the treatment of breast cancer and prostate cancer. It is also recognized as an extremely cost-effective treatment compared with other cancer treatments. These factors are driving the adoption of single-dose radiotherapy services for breast cancer and prostate cancer.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for single-dose radiotherapy. The report tracks the global sales of single-dose radiotherapy in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on radiotherapy services in general, and single-dose radiotherapy services in particular.
How the Historical and Future Outlook of Single Dose Radiotherapy Market Match Up?
Breast cancer is a progressive disease affecting more than 2 million people, worldwide. It has a significant impact on mortality in females. Similarly, approximately 1.4 million men aged 45 years and older across the world are diagnosed with prostate cancer. The growing incidence of breast cancer and prostate cancer has propelled the growth of the single-dose radiotherapy services market.
Previously due to insufficient clinical data about single-dose radiotherapy, it is not used widely in the treatment of early-stage breast cancer and prostate cancer. Whereas, Currently several clinical trials for use of single-dose radiotherapy is going on to prove its efficacy and safety to treat patients in the early stage of cancer, which we further believe to practice by a various radiologist to reduce time and cost associated with multiple fraction radiotherapy
According to FMI’s analysis, single-dose radiotherapy sales have grown at a 6.1% CAGR between 2015 and 2019. The COVID-19 pandemic has changed the national healthcare urgencies and expenditure but this is considered to be a short-term impact on the single-dose radiotherapy services market.
The market is expected to experience a short-term negative impact owing to a sharp reduction in the number of single-dose radiotherapy services adoption rate across the world. It is expected to recover by mid-2021. As the spread of COVID19 continues, key players are focusing on a novel methods to offer treatment for COVID-19 associated pneumonia using external beam radiation with a single low dose, entitled “Single-Dose Radiation Therapy” (SDRT).
There are multiple historical cohort studies mostly reported from the 1930s that report the administration of a single low dose of radiation (usually less than 0.5 Gy) to treat bacterial and viral pneumonia. It has been observed that it may treat coronavirus disease effectively. This is providing an opportunity for the single-dose radiotherapy services to grow soon.
FMI expects the global single-dose radiotherapy services market to grow at 6.1% CAGR through 2030.
How is Shift Towards Radiotherapies in combination with surgery for Breast Cancer Treatment Influence Single-Dose Radiotherapy Demand?
Single-dose of targeted radiotherapy was just as effective as conventional radiotherapy for women with early breast cancer and is considered as promising treatment immediately after lumpectomy surgery. In this approach, a single large dose of radiation is given to the area where the tumor bed was removed in the operative room right before the breast incision (BCS) is closed. Single-dose radiotherapy is associated with various therapeutic advantages such as high precision, targeted radiation, minimum treatment time, and radiation control. Thus, used in the initial stage of breast cancer treatment. Single-dose radiotherapy is a cost-effective and safer treatment option when compared with conventional external beam radiotherapies.
For instance, oncologists at TARGIT Collaborative Group (TCG) are working on the development of novel single-dose radiotherapy known as TARGIT-IORT. As per their finding, TARGIT-IORT is the type of single-dose radiotherapy in which targeted radiation delivered inside the breast during surgery within a few minutes following the removal of the tumour. 8 patients out of 10 having TARGIT-IORT immediately after lumpectomy, did not require any radiotherapy procedures post the combination procedure.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
What is the Potential of Single-Dose Radiotherapy in Prostate Cancer Treatment?
According to the European Society for Radiotherapy and Oncology (ESTRO), a single high dose of radiation that can be delivered directly to the r tumour immediately after surgery is a safe and effective technique for treating men with low to moderate risk prostate cancer. Numerous studies are underway for the development of various single-dose radiotherapies to reduce the number of prostate cancer reoccurrence cases.
Cancer researchers have major opportunities for new treatment launches with single-dose radiotherapy using different radiation doses to minimize hospital visits and complications such as reoccurrence of prostate cancer. Respondents have repeatedly noted that there is a large unmet need for treatments in prostate cancer and single-dose radiotherapy is one of the plausible treatments applicable for the geriatric with low to intermediate risk.
This opportunity exists in the U.S, since there is wide acceptance for single-dose radiotherapy in low doses as much as used in performing conventional external beam radiotherapy. As such doctors have repeatedly stated that this amount of radiotherapy is considered safe in the geriatric population and the risk of radiation-induced cancer is negligible. Thus the adoption of single-dose radiotherapy with or without supportive therapy is recommended by a radiologist, which will create huge demand for the single-dose radiotherapy services market in recent years.
How is Lack of Skilled Professionals Restraining Single-Dose Radiotherapy Growth?
Single-dose radiotherapy is the most advanced method for treatment of breast cancer and prostate cancer. It requires highly trained or skilled professionals to operate the radiotherapy device. Since it is fully automated and provides a targeted dose of radiation, its operability requires a skilled person for giving inputs to the radiotherapy machines such as the strength of radiation, placement parameters etc, which as a result may limit the use of single-dose radiotherapy.
In developing countries, insufficient facilities for radiotherapy and inadequate education and training about radiotherapy procedures results in the lack of skilled healthcare professionals to carry out single-dose radiotherapy, which can be a major restraint for the growth of the global single-dose radiotherapy services market.
What Are Opportunities Involved In Single-Dose Radiotherapy?
Various government agencies such as the United Nations Agency, International Atomic Energy Agency (IAEA) have included radiotherapy in their human health portfolio. IAEA provides extensive research, advisory functions, quality assurance, and education for awareness of radiotherapy, which creates huge opportunities for single-dose radiotherapy service providers in the developed region.
Most of the healthcare professionals in developed regions such as North America and Europe are recommending single-dose radiotherapy in the early stage of cancer due to its advantages such as reduced fractionation, decreased toxicities, shorter treatment interval, and fewer visits to hospitals that result in greater convenience for patients.
For instance, According to British Medical Association (BMA) report published in 2020, single-dose radiotherapy is related to about an 80% chance of escaping multiple fractions of conventional radiotherapy, lesser side effects, and no difference in survival or chances of cancer returning, thus used widely for the treatment of breast cancer in the 32 centres in 10 countries including UK, Europe, USA and Canada.
How Big is the Opportunity in the US?
The healthcare system of the U.S. is well-known for its advanced structure and spending. The care regime of the cancer care centers and hospitals are abode by the regulatory rules and insurance policies. The huge hospital bills experienced other than Medicare accelerates the market growth in the country.
The government and regulatory authorities in the U.S. are implementing several cost-containment plans to ease the burden on healthcare. The U.S. government is actively taking initiatives to encourage various research activities for the development and treatment plan for single-dose radiotherapy for cancer.
For instance, in 2019, the American Cancer Society has funded more than $67 million in breast cancer research through 162 research and training grants. Similarly, the American Cancer Society Cancer Action Network (ACS CAN) increased funding for the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), at both the state and federal levels.
Furthermore, due to the higher prevalence of breast cancer and prostate cancer in the U.S., many service providers are conducting campaigns to raise general awareness among people related to these diseases. This is likely to support the overall market growth in the country.
Automation in Radiation Therapy Key to Succeed in U.K.
Radiation therapy departments at hospitals and cancer research institutes in the U.K. are focusing on standardizing the processes involved in radiation therapy and maintaining compliance with departmental policies.
Automation in radiation therapy is introduced using artificial intelligence, big data analysis, and other technologies. Automation is resulting in the use of different control systems used for operating equipment involved in single-dose radiotherapy procedures. This reduces human intervention during the procedure, and eliminates human errors.
These benefits associated with automation, hospitals and cancer research institutes in the U.K. are increasing the adoption of radiation therapy, which is projected to boost the revenue growth in the U.K. over the forecast period.
For instance, the National Institute for Health and Care Excellence (NICE), an organization that guides to improve health and social care in the U.K., has permitted intraoperative radiation therapy (IORT), an advanced type of single dose radiotherapy given at the same time as surgery to remove a tumour, as standard practice for patients with early-stage breast cancer.
What are Restricting Single-dose radiotherapy in South Africa ?
Both prostate cancer and breast cancer are progressive diseases that majorly affect the geriatric population. Lack of awareness of breast cancer and prostate cancer and insufficient treatment options are leading to increasing incidence of these type of cancers.
Due to limited campaigning about the assessment of cancers, there seems to occur minimum practice of radiotherapy in hospitals in South Africa. Furthermore, insufficient healthcare facilities in South Africa as compared to the developed countries is hampering the growth.
What Is Supporting Surging Adoption Of Single Dose Radiotherapy In China?
Growth in South Asia is anticipated to happen at an accelerated pace through forecast years. The World Health Organization reported that in 2018 the incidence rate of “westernized lifestyle-related cancer” such as prostate cancer in males, together with obesity and hormonal exposure-related cancers like breast cancer in females showed an upward trend in China.
A nationwide survey conducted in China revealed that about 13.8% of females in China are suffering from breast cancer and 19.25% of males are suffering from prostate cancer in 2018. Based on results revealed in the Global Burden of Disease Study, breast cancer and prostate cancer are the leading cause of death among the top 5 types of cancer in the country in 2018.
These figures are indicative of opportunities for wider penetration in China, subsequently South Asia. A rise in the prevalence of breast cancer and prostate cancer in China is another key factor driving rapid growth in the market.
Why External Beam Radiotherapy More Preferred?
External beam radiotherapy is widely used for breast cancer and prostate cancer treatment. Due to easy operability and noninvasiveness, most physicians opt for external beam radiotherapy. Since external beam radiotherapy is costly, various service providers offer reimbursements for such radiotherapy procedures. The cost of a single dose external beam radiotherapy is more for prostate cancer when compared with a breast cancer patient, which results in the highest revenue in the single-dose radiotherapy services market.
What’s the Market Share of Radiotherapy Centers?
The radiotherapy centers segment will continue to grow and dominate the market during the forecast period. According to FMI, the segment is expected to hold around 40% of the market share, in terms of service providers, by the end of 2030. Radiotherapy Centers are equipped with advanced, fully automatic radiotherapy facilities to treat patient with various types of cancer.
Which Indication Exhibits High Demand for Single Dose Radiotherapy?
Breast cancer currently leads the market in terms of indication. The increasing prevalence of breast cancer around the world will continue supporting growth. The American Cancer Society has identified breast cancer as the most common type of cancer affecting American women. Also as per the American Institute of Cancer Research there were over 2 million new cases of breast cancer in the world in 2018.
With the incidence set to rise, the demand for effective therapy is forecast to surge. This will in turn fuel the demand for single dose radiotherapy in the coming years.
Scope of the Report
Historical Data Available for
USD Million for Value
Key Regions Covered
North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa
Key Countries Covered
US, Canada, Germany, U.K., France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa
Key Segments Covered
Indication, Therapy, Service Provider, and Region
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing
Key Questions Answered in the Report
Which is the most lucrative market for single-dose radiotherapy?
The US currently leads the global market for single-dose radiotherapy. Sales in the US will be over 37% of the total global demand throughout the forecast period.
Which is the most used type of radiotherapy?
External beam radiotherapy is dominating the segment in terms of therapy. Due to its ease of operability and noninvasiveness, the demand for external beam radiotherapy will continue increasing through the forecast period.
Which service provider is driving revenue of single-dose radiotherapy?
Radiotherapy centers are leading the service provider segment of the single-dose radiotherapy services market, owing to their advanced medical facilities and higher footfall of patients.
Enquiry Before Buying
Is this research conducted by Future Market Insights?
Yes, the research has been conducted by expert analysts of Future Market Insights through a combination of primary research and secondary research. To know more about how the research was conducted, you can speak to a research analyst
What research methodology is followed by FMI?
FMI follows a methodology that encompasses the demand-side assessment of the market and triangulates the same through supply-side analysis. This methodology is based on the use of standard market structure, methods and definitions. Request detailed methodology
Who are the respondents for primary research?
FMI speaks to service providers across the spectrum, including radiologists, radiotherapy technicians, doctors and cancer researchers. For a full list of primary respondents, please reach out to us.
What are the sources of secondary research?
FMI conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Is a sample of this report available for evaluation?
Yes, you can request a sample and it will be sent to you through an email.
How can I buy this report?
FMI provides a secure online payment system to buy report seamlessly. You can buy the report securely and safely.
Single-Dose Radiotherapy Services Market by Category
- Breast Cancer
- Prostate Cancer
- External Beam Radiotherapy
- Internal Beam Radiotherapy
- Radiotherapy Centers
- Specialized Cancer Institutes
- North America
- Latin America
- East Asia
- South Asia
- The Middle East and Africa (MEA)